Glenmark launches topical antifungal cream - Onabet
Glenmark Pharmaceuticals Ltd, one of India�s leading research-led, integrated pharmaceutical companies, launched its topical antifungal cream Onabet in the Indian market.
Glenmark Pharmaceuticals on Wednesday started Phase-IIb human trials of its 'Revamilast' molecule, which is being developed for treatment of inflammatory disorders like asthma and rheumatoid arthritis.